Valuation : Middle East Pharmaceutical Industries Company

Market Cap 2.27B 604M 518M 485M 444M 837M 57.65B 839M 5.74B 2.25B 29.05B 2.22B 96.16B P/E 2024
30.5x
P/E 2025 22.9x
Enterprise Value 2.3B 611M 525M 491M 450M 848M 58.4B 850M 5.82B 2.27B 29.43B 2.25B 97.41B EV / Sales 2024
6.29x
EV / Sales 2025 4.89x
Free-Float
46.88%
Yield 2024
1.64%
Yield 2025 2.18%
1 day+2.05%
1 week+9.19%
Current month+12.02%
1 month+8.55%
3 months+8.92%
6 months+8.64%
Current year+1.90%
1 week 58.85
Extreme 58.85
64.8
1 month 57.55
Extreme 57.55
64.8
Current year 53.89
Extreme 53.885712
68.51
1 year 53.89
Extreme 53.885712
79.09
3 years 51.54
Extreme 51.542856
112.91
5 years 51.54
Extreme 51.542856
112.91
10 years 51.54
Extreme 51.542856
112.91
Manager TitleAgeSince
Chief Executive Officer 45 05/09/2018
Director of Finance/CFO - 11/03/2024
Chief Tech/Sci/R&D Officer 51 01/01/2023
Director TitleAgeSince
Chairman 54 10/04/2022
Director/Board Member 45 13/09/2023
Director/Board Member 45 10/04/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.05%+9.19%-12.50% - 591M
+0.73%+0.70%+19.56%+71.29% 47.78B
-0.37%+1.04%+54.31%+121.86% 40.3B
+1.23%-0.14%-10.12%+15.55% 11.88B
+3.41%+7.67%+20.38%+87.48% 12.03B
+0.19%0.00%+30.98%+150.00% 9.24B
+0.45%+3.73%+25.09%+46.01% 7.83B
-1.41%-0.16%+52.26%-11.99% 7.34B
+0.89%+9.50%+26.11%+220.67% 7.21B
+0.95%-8.22%-39.88%+16.67% 5.28B
Average +0.81%+1.91%+16.62%+79.73% 14.95B
Weighted average by Cap. +0.56%+1.09%+27.33%+86.59%

Financials

2024 2025
Net sales 394M 105M 90.08M 84.34M 77.22M 145M 10.02B 146M 999M 390M 5.05B 385M 16.72B 460M 123M 105M 98.57M 90.26M 170M 11.71B 171M 1.17B 456M 5.9B 451M 19.54B
Net income 79.85M 21.27M 18.26M 17.09M 15.65M 29.48M 2.03B 29.57M 202M 79.12M 1.02B 78.12M 3.39B 97.01M 25.84M 22.18M 20.76M 19.01M 35.82M 2.47B 35.92M 246M 96.12M 1.24B 94.91M 4.12B
Net Debt 42.83M 11.41M 9.79M 9.17M 8.4M 15.81M 1.09B 15.86M 109M 42.44M 549M 41.91M 1.82B 29.47M 7.85M 6.74M 6.31M 5.78M 10.88M 750M 10.91M 74.7M 29.2M 378M 28.84M 1.25B
Logo Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Employees
731
Date Price Change Volume
27/08/26 SAR 64.75 +2.05% 188,127
26/08/26 SAR 63.45 +2.17% 153,124
25/08/26 SAR 62.10 -1.04% 74,011
24/08/26 SAR 62.75 +1.21% 157,698
23/08/26 SAR 62.00 +0.81% 106,139
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
64.75SAR
Average target price
146.40SAR
Spread / Average Target
+126.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4016 Stock